Your browser has either disabled or does not support javascript. Javascript is required for full website experience.
Bellicum Pharmaceuticals Inc
BLCM
$
4.37
-2.2%
Thu January 7th, 2021
13:19
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
Press Releases
Analysis
Zacks.com featured highlights include: Bellicum Pharmaceuticals, Prometic Life Sciences, Vaccinex, Meridian Bioscience and 360 DigiTech
Zacks
Fri December 25th, 2020
17:00
Rating
Analysis
Bellicum Pharmaceuticals (BLCM) Upgraded to Buy: Here's Why
Zacks
Fri November 20th, 2020
17:00
Rating
Analysis
Bellicum Pharmaceuticals (BLCM) Upgraded to Buy: Here's What You Should Know
Zacks
Fri October 30th, 2020
11:42
Rating
Bellicum Pharmaceuticals downgraded to neutral from buy at Ladenburg Thalmann
MarketWatch
Wed September 16th, 2020
00:10
Analysis
Bellicum Pharmaceuticals: Accumulating At This Valuation
Seeking Alpha
Fri September 11th, 2020
21:38
Analysis
Bellicum Pharmaceuticals (BLCM) Investor Presentation - Slideshow
Seeking Alpha
Fri August 7th, 2020
02:27
Earnings
Analysis
Bellicum Pharmaceuticals, Inc. (BLCM) CEO Richard Fair on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha
Wed May 27th, 2020
11:30
Press Releases
Bellicum to Participate in Two Upcoming Virtual Investor Conferences
Benzinga
Fri May 22nd, 2020
16:00
Rating
Analysis
All You Need to Know About Bellicum Pharmaceuticals (BLCM) Rating Upgrade to Strong Buy
Zacks
